Notice Number: NOT- NS-16-007

Key Dates
Release Date: February 11, 2016

Issued by
National Institute of Neurological Disorders and Stroke (NINDS)
National Cancer Institute (NCI)
National Eye Institute (NEI)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
National Institute of Dental and Craniofacial Research (NIDCR)
National Center for Advancing Translational Sciences (NCATS)
National Institute of Nursing Research (NINR)

Purpose

The purpose of this notice is to clarify the Technology Transfer contact information for PA-15-354, "SBIR Technology Transfer (R43/R44)".

The current language reads:

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

SBCs are encouraged to submit a license application to the NIH Office of Technology Transfer (OTT) before submitting an SBIR application. The SBIR application will be reviewed by the NIH Center for Scientific Review (CSR), while license applications will be reviewed by the NIH Office of Technology Transfer. Under the NIH SBIR-TT program, the SBIR grant review process will be conducted in parallel with, but distinct from, the review of any application for a license. A list of relevant technical, invention, and licensing-related answers can be found online at the NINDS Technology Transfer Office: http://www.ott.nih.gov/.

The language has been modified and now reads:

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

If selected for SBIR funding, the SBC will be granted a royalty-free, non-exclusive, internal research-use license to the United States Government’s intellectual property for the eligible inventions from the intramural programs of the appropriate Institute, with the intent that the SBC will advance development of the technology toward a commercial product to benefit the public, consistent with the missions of that Institute. The internal use license will be for the term of award and for performance of work under the SBIR award. The SBC will be required to have a commercial license executed by the appropriate Institute prior to award of an SBIR Phase II grant. This commercial license may be applied for at any time, but will not be reviewed until Phase I is awarded. The SBIR application will be reviewed by the NIH Center for Scientific Review (CSR), while license applications will be reviewed by the appropriate NIH IC Technology Transfer Office. Under the NIH SBIR-TT program, the SBIR grant review process will be conducted in parallel with, but distinct from, the review of any application for a license. A list of relevant technical, invention, and licensing-related answers can be found online at http://www.ott.nih.gov/ or at the technology transfer office website of the appropriate NIH Institute or Center (IC) (For IC technology transfer offices, see "Quick Links" on the NIH IC Technology Development Coordinators page at http://www.ott.nih.gov/technology-development-coordinators).

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Stephanie Fertig, M.B.A.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
Email: fertigs@ninds.nih.gov